Front. Psychiatry Frontiers in Psychiatry Front. Psychiatry 1664-0640 Frontiers Media S.A. 10.3389/fpsyt.2024.1523364 Psychiatry Correction Corrigendum: Physical disability and psychedelic therapies: an agenda for inclusive research and practice Mintz Kevin T. 1 * Gammer Brinn 2 Khan Amanda J. 3 4 Shaub Gretchen 5 Levine Steven 5 Sisti Dominic 2 1 Stanford University, Center for Biomedical Ethics, Stanford, CA, United States 2 Department of Medical Ethics & Health Policy, University of Pennsylvania, Philadelphia, PA, United States 3 Department of Psychiatry, University of California, San Francisco, San Francisco, CA, United States 4 Sage Integrative Health, Berkeley, CA, United States 5 COMPASS Pathways, London, United Kingdom

Edited and Reviewed by: Marijn Lijffijt, IonTX, Inc, United States

*Correspondence: Kevin T. Mintz, kmintz@stanford.edu

23 12 2024 2024 15 1523364 05 11 2024 22 11 2024 Copyright © 2024 Mintz, Gammer, Khan, Shaub, Levine and Sisti 2024 Mintz, Gammer, Khan, Shaub, Levine and Sisti

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Physical disability and psychedelic therapies: an agenda for inclusive research and practice By Mintz KT, Gammer B, Khan AJ, Shaub G, Levine S and Sisti D (2022) Front. Psychiatry 13:914458. doi: 10.3389/fpsyt.2022.914458 physical disability sensory disability psychedelic therapies ethics structural ableism in healthcare justice inclusion in clinical research section-in-acceptance Psychopharmacology

In the published article, there were errors in Table 2 . The authors wish to correct the errors and clarify data presented in Table 2 , pertaining to the prevalence of mental illness in several populations.

Disability community prevalence of mental disorders.

Disabling condition Prevalence within disability communities Source
MS   ALSMild/Moderate Cerebral Palsy a   Spinal cord injury  Traumatic brain injury     Deafness b     Blindness c MDD - 46%Anxiety - 16.5%Bipolar - 2.4%Schizophrenia -.2%MDD - 17%Anxiety Disorders - 19.5%Mood Disorders - 19.5%Schizophrenia - 2.8%MDD - 20-30%Anxiety - 13.2-40%PTSD - 7.1–26.6%MDD - 24.5%Anxiety - 24.5%Bipolar - ~1.6%Schizophrenia - 4.0%PTSD - 16.5%Substance Use Disorder - 11.5%Anxiety Disorders – 18.7%Bipolar – 3.7%Impulse control disorders – 15.8%Substance Use Disorders – 27.8%ADHD – 11.2%MDD - 18.2%Anxiety Disorders - 14.3%Schizophrenia - 1.4%Alcohol Misuse - 3.3%Psychoactive Substance Misuse - 12.9%Anorexia or Bulimia -.5% Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T, 2009 (33) Zucchi E, Ticozzi N, Mandrioli J, 2019 (34)Whitney DG, Warschausky SA, Ng S, Hurvitz EA, Kamdar NS, Peterson MD, 2019 (35) a Post M, van Leeuwen, C, 2012 (36) Rogers JM, Read CA, 2007 (37) Diaz DR, Landsberger SA, Povlinski J, Sheward J, Sculley C, 2013 (38) b Court H, McLean G, Guthrie B, Mercer SW, Smith DJ, 2014 (39) c

Statistics in this table reflect the statistics for men with CP in this article.

This article is focused on a population in outpatient psychiatric care.

This article is focused on patients 65 and older in the UK.

The authors thank Jacob Kramer, an MSW student at Rhode Island College for helping bring these errors to our attention, particularly with regard to the D/deaf community.

Under “Mild/Moderate Cerebral Palsy”, the data in column 2 refer to men only. A footnote has been added to clarify this.

Under “Spinal cord injury”, the data in column 2 were reported as 7.1–26.6% and 13.2-40% for Anxiety and PTSD, respectively. The correct values are 13.2–40% and 7.1–26.6%. The table has been updated to reflect this.

Under “Deafness”, the data for Substance Use Disorder in column 2 reflect a population in outpatient psychiatric care. A footnote has been added to clarify this.

Also under “Deafness”, the data in column 2 were reported as 30.1%, 14.2%, 5.2%, 48.4% and 4.9% for Anxiety, Bipolar, Impulse control disorders, Substance Use Disorders and ADHD, respectively. The correct values are 18.7%, 3.7%, 15.8%, 27.8% and 11.2%. The table has been updated to reflect this.

Under “Blindness”, the data in column 2 refer to patients older than 65. A footnote has been added to clarify this.

The corrected Table 2 and its caption appear below.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.